Loss-of-function mutations of the TET2 gene are commonly detected in hematopoietic tumors, such as acute myeloid leukemia, chronic myelomonocytic leukemia, and peripheral T cell lymphomas (36). The gene discussed is TET2; the disease is peripheral T-cell lymphoma, not otherwise specified.